Who Paid My Doc
Paul Butros
Diagnostic Radiology Warrenton, VA Medical Doctor
NPI 1316142029 CMS profile 656358
550 Broadview Ave Ste 102, Warrenton, VA 20186
General payments
$127,485
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$50,048
Through program year 2025, Paul Butros of Warrenton, VA is reported in the CMS Open Payments database as having received $127,485 across 130 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $50,048 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $29,149 | 5 | |
| 2024 | General | $30,153 | 8 | |
| 2023 | General | $30,795 | 27 | |
| 2022 | General | $22,671 | 35 | |
| 2021 | General | $12,921 | 29 | |
| 2020 | General | $1,627 | 20 | |
| 2019 | General | $169 | 6 |
Beside peers
- Paul Butros
- Diagnostic Radiology median
- Middle half of Diagnostic Radiology
- National median
In program year 2025, general payments to Paul Butros were reported at $29,149. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.
Show as a table
| Year | Paul Butros | Diagnostic Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $169 | $108 | $29–$318 | $163 |
| 2020 | $1,627 | $65 | $21–$252 | $114 |
| 2021 | $12,921 | $92 | $24–$292 | $132 |
| 2022 | $22,671 | $104 | $29–$294 | $149 |
| 2023 | $30,795 | $110 | $29–$337 | $160 |
| 2024 | $30,153 | $113 | $30–$356 | $164 |
| 2025 | $29,149 | $112 | $32–$349 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
245
Drug cost
$34,622
Branded share of claims
63.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 23 | $22,314 | |
| Xarelto Rivaroxaban | Brand | 17 | $9,857 | |
| Clopidogrel Clopidogrel Bisulfate | Brand | 116 | $1,431 | |
| Rosuvastatin Calcium | Generic | 53 | $615 | |
| Cilostazol | Generic | 11 | $221 | |
| Atorvastatin Calcium | Generic | 25 | $184 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 84 billing codesPaid by Medicare
$1,240,273
Medicare patients
389
Services billed
7,531
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 61% | |
| Diabetes | 47% | |
| Ischemic heart disease | 39% | |
| Chronic kidney disease | 39% | |
| Heart failure | 29% | |
| Atrial fibrillation | 26% | |
| Depression | 24% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 | Office | 78 | 5,633 | $598 |
| Injection, fentanyl citrate, 0.1 mg J3010 | Office | 48 | 136 | $96 |
| Injection, midazolam hydrochloride, per 1 mg J2250 | Office | 46 | 148 | $16 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
130 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Diagnostic Radiology in Virginia
Ray Beauchamp
Diagnostic Radiology · Richmond, VA
Ravi Kamath
Diagnostic Radiology · Fairfax, VA
Melany Atkins
Diagnostic Radiology · Fairfax, VA
Luke Lancaster
Diagnostic Radiology · Charlottesville, VA
Colin Derdeyn
Diagnostic Radiology · Charlottesville, VA
Michael Hanley
Diagnostic Radiology · Charlottesville, VA
Related records
Diagnostic Radiology in Virginia
Practitioners in the same specialty and state, ranked by reported value.
All Diagnostic Radiology
Everyone recorded under this specialty, nationwide.
Doctors in Virginia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.